Overweight/obesity Nutritional, Metabolic, Endocrine Obesity
Conditions
Interventions
Subjects gave their written consent for participation in the program and were required to attend group lectures on general health, diet, and exercise, every two weeks given by Dr Lyon for a 14 week pe
Sponsors
Factors Group of Nutritional Companies Inc. (Canada)
Eligibility
Inclusion criteria
Inclusion criteria: 1. 20 to 65 year of age 2. Body mass index range of approximately 23 kg/m^2 to 35 kg/m^2 3. Otherwise healthy
Exclusion criteria
Exclusion criteria: 1. Morbid obesity 2. Major psychiatric diagnosis 3. Use of other weight loss medications such as sibutramine or ephedra
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcomes measured for all participants are weight (pounds), waist and hip circumference, and percent body fat. Percent body fat was determined using bioelectrical impedance testing at baseline and every two weeks thereafter. | — |
Secondary
| Measure | Time frame |
|---|---|
| All subjects enrolled in the program were initially evaluated for High Density Lipoprotein (HDL), LDL, total cholesterol, triglycerides, fasting glucose, fasting insulin, two hour fasting insulin, and 75 gram glucose tolerance test at baseline, only those with aberrant risk factors were re-tested using the latter laboratory parameters at week 14. | — |
Countries
Canada
Outcome results
None listed